BLOOD PLASMA
Humoral Primary Immunodeficiencies (PIDs)
Assistance Publique - Hôpitaux de Parisother_biologicalActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
11 Active assets in the Humoral Primary Immunodeficiencies (PIDs) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Busulphan medac GmbH | Phase 2 | B |
Fludarabine Paul Szabolcs | Phase 2 | B |
Treosulfan medac GmbH | Phase 2 | B |
Evomela Paul Szabolcs | Phase 2 | CCC |
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Paul Szabolcs | Phase 2 | CCC |
View all 15 →
Same molecule, other indications
BLOOD PLASMA is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →